Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P van Meerbeeck

Showing results (21-30 of 250) with videos related to

Pageof 25
Sort By:
Revue Des Maladies Respiratoires|November 26, 2008
[Other thoracic cancers. Small-cell lung cancer: an update]K Vermaelen, J-P van Meerbeeck
American Journal of Respiratory and Critical Care Medicine|October 4, 2008
Screening for mesothelioma: more harm than good?Jan P van Meerbeeck, Gunnar Hillerdal
EJC Supplements : EJC : Official Journal of EORTC, European Organization for Research and Treatment of Cancer ... [Et Al.]|July 29, 2015
The seventh tumour-node-metastasis staging system for lung cancer: Sequel or prequel?Jan P van Meerbeeck, Annelies Janssens
Acta Anaesthesiologica Belgica|December 1, 1981
Axillary approach of brachial plexus blockJ P van Meerbeeck, F Gheur
Lung Cancer (Amsterdam, Netherlands)|June 14, 2005
Consensus report: pretreatment minimal staging and treatment of potentially resectable malignant pleural mesotheliomaJan P van Meerbeeck, Michael Boyer
Lancet (London, England)|September 19, 2014
Small-cell lung cancer: local therapy for a systemic disease?Jan P van Meerbeeck, David Ball
The European Respiratory Journal|August 11, 2018
Lung cancer staging: imagine fewer imagesKurt G Tournoy, Jan P Van Meerbeeck
Translational Lung Cancer Research|November 20, 2018
The use of patient-reported outcome measures (PROMs) in the management of malignant pleural mesothelioma: a descriptive literature surveyYoussef Ben Bouazza, Jan P Van Meerbeeck
Seminars in Oncology|February 12, 2002
The role of gemcitabine in the treatment of malignant mesotheliomaHedy Lee Kindler, Jan P van Meerbeeck
Expert Review of Anticancer Therapy|October 18, 2011
Raltitrexed in mesotheliomaVeerle F Surmont, Jan P van Meerbeeck
Pageof 25

Showing results (21-30 of 250) with videos related to

Sort By:
Pageof 25
Revue Des Maladies Respiratoires|November 26, 2008
[Other thoracic cancers. Small-cell lung cancer: an update]K Vermaelen, J-P van Meerbeeck
American Journal of Respiratory and Critical Care Medicine|October 4, 2008
Screening for mesothelioma: more harm than good?Jan P van Meerbeeck, Gunnar Hillerdal
EJC Supplements : EJC : Official Journal of EORTC, European Organization for Research and Treatment of Cancer ... [Et Al.]|July 29, 2015
The seventh tumour-node-metastasis staging system for lung cancer: Sequel or prequel?Jan P van Meerbeeck, Annelies Janssens
Acta Anaesthesiologica Belgica|December 1, 1981
Axillary approach of brachial plexus blockJ P van Meerbeeck, F Gheur
Lung Cancer (Amsterdam, Netherlands)|June 14, 2005
Consensus report: pretreatment minimal staging and treatment of potentially resectable malignant pleural mesotheliomaJan P van Meerbeeck, Michael Boyer
Lancet (London, England)|September 19, 2014
Small-cell lung cancer: local therapy for a systemic disease?Jan P van Meerbeeck, David Ball
The European Respiratory Journal|August 11, 2018
Lung cancer staging: imagine fewer imagesKurt G Tournoy, Jan P Van Meerbeeck
Translational Lung Cancer Research|November 20, 2018
The use of patient-reported outcome measures (PROMs) in the management of malignant pleural mesothelioma: a descriptive literature surveyYoussef Ben Bouazza, Jan P Van Meerbeeck
Seminars in Oncology|February 12, 2002
The role of gemcitabine in the treatment of malignant mesotheliomaHedy Lee Kindler, Jan P van Meerbeeck
Expert Review of Anticancer Therapy|October 18, 2011
Raltitrexed in mesotheliomaVeerle F Surmont, Jan P van Meerbeeck
Pageof 25